More notably, administration of CuII(atsm) to ALS-model mice was found to significantly reduce abnormal phosphorylation and truncation of TDP-43 [103], both of which are pathological hallmarks of sALS cases without mutations in SOD1. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.